Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Werfel

Showing results (101-110 of 404) with videos related to

Pageof 41
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|April 9, 2002
Suppression of IL-12 production by soluble CD40 ligand: evidence for involvement of the p44/42 mitogen-activated protein kinase pathwayMiriam Wittmann, Petra Kienlin, Susanne Mommert, et al.
International Journal of Environmental Research and Public Health|April 5, 2020
Contact Allergy-Emerging Allergens and Public Health ImpactWolfgang Uter, Thomas Werfel, Jean-Pierre Lepoittevin, et al.
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|November 11, 2020
[Recommendations when switching therapy from immunosuppressive drugs to dupilumab in patients with atopic dermatitis]Johannes Wohlrab, Ulrich Mrowietz, Stephan Weidinger, et al.
Arthritis and Rheumatism|September 30, 2008
Evidence for a pathogenetic role of interleukin-18 in cutaneous lupus erythematosusDong Wang, Melanie Drenker, Britta Eiz-Vesper, et al.
Respiration; International Review of Thoracic Diseases|November 26, 2023
Adverse Effects Under Th2 Biologics (Dupilumab and Tezepelumab) in a Patient with Severe Asthma and Atopic DermatitisHendrik Suhling, Christopher Alexander Hinze, Tobias Welte, et al.
Scientific Reports|October 3, 2023
Inhibition of IL-17 ameliorates keratinocyte-borne cytokine responses in an in vitro model for house-dust-mite triggered atopic dermatitisJuliane Haertlé, Petra Kienlin, Gabriele Begemann, et al.
Allergy|June 15, 2021
Expression of histamine receptors H2R and H4R are predominantly regulated via the IL-4/IL-13 receptor type II on human M2 macrophagesSusanne Mommert, Martin Jahn, Katrin Schaper-Gerhardt, et al.
Handbook of Experimental Pharmacology|July 5, 2021
Comprehensive Approach: Current Status on Patient Education in Atopic Dermatitis and Other Allergic DiseasesStephan Traidl, Claudia Lang, Peter Schmid-Grendelmeier, et al.
British Journal of Pharmacology|July 23, 2019
Histamine up-regulates oncostatin M expression in human M1 macrophagesSusanne Mommert, Marius Hüer, Katrin Schaper-Gerhardt, et al.
Experimental Dermatology|August 21, 2008
Intracutaneous injection of the macrophage-activating lipopeptide-2 (MALP-2) which accelerates wound healing in mice--a phase I trial in 12 patientsMargarete Niebuhr, Peter F Mühlradt, Miriam Wittmann, et al.
Pageof 41

Showing results (101-110 of 404) with videos related to

Sort By:
Pageof 41
Journal of Immunology (Baltimore, Md. : 1950)|April 9, 2002
Suppression of IL-12 production by soluble CD40 ligand: evidence for involvement of the p44/42 mitogen-activated protein kinase pathwayMiriam Wittmann, Petra Kienlin, Susanne Mommert, et al.
International Journal of Environmental Research and Public Health|April 5, 2020
Contact Allergy-Emerging Allergens and Public Health ImpactWolfgang Uter, Thomas Werfel, Jean-Pierre Lepoittevin, et al.
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|November 11, 2020
[Recommendations when switching therapy from immunosuppressive drugs to dupilumab in patients with atopic dermatitis]Johannes Wohlrab, Ulrich Mrowietz, Stephan Weidinger, et al.
Arthritis and Rheumatism|September 30, 2008
Evidence for a pathogenetic role of interleukin-18 in cutaneous lupus erythematosusDong Wang, Melanie Drenker, Britta Eiz-Vesper, et al.
Respiration; International Review of Thoracic Diseases|November 26, 2023
Adverse Effects Under Th2 Biologics (Dupilumab and Tezepelumab) in a Patient with Severe Asthma and Atopic DermatitisHendrik Suhling, Christopher Alexander Hinze, Tobias Welte, et al.
Scientific Reports|October 3, 2023
Inhibition of IL-17 ameliorates keratinocyte-borne cytokine responses in an in vitro model for house-dust-mite triggered atopic dermatitisJuliane Haertlé, Petra Kienlin, Gabriele Begemann, et al.
Allergy|June 15, 2021
Expression of histamine receptors H2R and H4R are predominantly regulated via the IL-4/IL-13 receptor type II on human M2 macrophagesSusanne Mommert, Martin Jahn, Katrin Schaper-Gerhardt, et al.
Handbook of Experimental Pharmacology|July 5, 2021
Comprehensive Approach: Current Status on Patient Education in Atopic Dermatitis and Other Allergic DiseasesStephan Traidl, Claudia Lang, Peter Schmid-Grendelmeier, et al.
British Journal of Pharmacology|July 23, 2019
Histamine up-regulates oncostatin M expression in human M1 macrophagesSusanne Mommert, Marius Hüer, Katrin Schaper-Gerhardt, et al.
Experimental Dermatology|August 21, 2008
Intracutaneous injection of the macrophage-activating lipopeptide-2 (MALP-2) which accelerates wound healing in mice--a phase I trial in 12 patientsMargarete Niebuhr, Peter F Mühlradt, Miriam Wittmann, et al.
Pageof 41